… Associations between IgG and IgM anti-MDA-LDL antibody levels and CV events were
abolished after adjustment for total serum IgG and IgM levels respectively (Table 4, model 3). The …

… factor, pregnancy-associated plasma protein-A, autoantibodies to apolipoprotein A-1, and
antibodies to phosphorylcholine levels; inflammation using C-reactive protein levels and …

… In addition to atherosclerosis as an underlying cause of CVD … ) leading to the antiphospholipid
antibody syndrome with both … Antibodies against phosphorylcholine (anti-PC) and other …

… cardiovascular outcomes in hypertensive patients. IBIS-3 analyzed lesions in a non-culprit
coronary artery … as antibodies reacting with phosphorylcholine or malondialdehyde (MDA) [ …

… is promoted by the pCRP binding to phosphocholine residues of … Tocilizumab is a monoclonal
humanized antibody acting by … due to its uncertain cardiovascular outcomes. The targeting …

… of oxidized phospholipids (OxPL) that contain phosphocholine. Polymorphisms in the LPA
(… of Lp(a) with sex-specific CV outcomes, using individual participant data from the UK …

… epitopes revealed by apoptosis such as phosphorylcholine, oxidation products such as …
circulating IgM antibodies to oxidized LDL, phosphorylcholine and nucleic acid antigens [37]. …

… association between IgM auto-antibodies and CVD risk [10, … a lower risk of CVD or less
severe cardiovascular outcomes [16, … More recently, IgA antibodies against phosphocholine and …

… For instance, autoantibodies recognize TLR4 or specific autoantigens such as β2GPI with …
involvement, and the levels of antioxidized palmitoyl arachidonoyl phosphocholine antibodies. …

… E06 natural antibody that recognizes the phosphocholine head … cardiovascular disease
(CVD), and predict new CVD events … biomarkers to cardiovascular outcomes in patients with prior …